×
戻る Agenda
Session 4: UK MHRA and BREXIT – Next Steps. Concrete Clinical Trials Disclosure Aspects
Session Chair(s)
Scott Feiner
Senior Manager, Trial Disclosure, AbbVie, United States
UK MHRA and BREXIT – Next Steps. Concrete Clinical Trials Disclosure Aspects
Speaker(s)
Scott Feiner
Senior Manager, Trial Disclosure, AbbVie, United States
Overview of Latest MHRA Guidance for Clinical Trials Post-Brexit
Amanda Hunn, MA
Self-employed Advisor/Formerly Head of Policy and Public Affairs At the HRA, AJ Hunn Associates, United Kingdom
Brexit and Clinical Trial Disclosure in the UK